Cancer Family
Nervous System Neoplasm
CI-CAN-00000038Explore in graph →
Non-malignant1,523 active trials9 approved drugs210 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000038Explore in graph →
Clinical trials
5,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03925675 | 18F-Fluciclovine PET and Multiparametric MR Imaging | withdrawn | Phase 2 | 0 | Loma Linda UniversityOTHER | 1 | Sep 3, 2024 | clinicaltrials |
| NCT06182410 | Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma | withdrawn | Phase 2 | 0 | University of California, San FranciscoOTHER | 0 | Aug 7, 2024 | clinicaltrials |
| NCT06335745 |
| PediCARE Health Equity Intervention in High-Risk Neuroblastoma |
| withdrawn |
| N/A |
| 0 |
| Dana-Farber Cancer InstituteOTHER |
| 0 |
| Aug 5, 2024 |
| clinicaltrials |
| NCT05082493 | A Multicenter, Study of the Safety and Pharmacokinetics of Intravenously Infused Berubicin in Pediatric Patients With Progressive, Refractory, or Recurrent High Grade Gliomas | withdrawn | Phase 1 | 0 | WPD Pharmaceuticals Sp. z o.o.INDUSTRY | 0 | Jun 6, 2024 | clinicaltrials |
| NCT03955068 | Strict Classic Ketogenic Diet as a Therapy for Recurrent or Progressive and Refractory Brain Tumors in Children | withdrawn | N/A | 0 | University of Texas Southwestern Medical CenterOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT01622764 | 89Zr-RO5323441 PET Imaging in Glioblastoma | withdrawn | Phase 2 | 0 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT05120960 | A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 17, 2024 | clinicaltrials |
| NCT05304663 | Safety and Efficacy of Different Administration Sequences of L19TNF With Lomustine in Glioblastoma at First Progression(GLIOASTRA) | withdrawn | Phase 1 | 0 | Philogen S.p.A.INDUSTRY | 0 | Apr 8, 2024 | clinicaltrials |
| NCT05952687 | Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors | withdrawn | Phase 1 | 0 | St. Jude Children's Research HospitalOTHER | 0 | Mar 27, 2024 | clinicaltrials |
| NCT05666349 | Reirradiation and Niraparib in Patients With Recurrent Glioblastoma(RiNG) | withdrawn | Phase 1 | 0 | University College, LondonOTHER | 0 | Mar 26, 2024 | clinicaltrials |
| NCT03935269 | Cereset for Caregivers(CERESET) | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 0 | Mar 20, 2024 | clinicaltrials |
| NCT05672082 | Contribution of [18F]DPA-714 PET for Grading and Exploration of the Inflammatory Microenvironment of Glioma.(INFLAGLI) | withdrawn | N/A | 0 | Center Eugene MarquisOTHER | 0 | Feb 8, 2024 | clinicaltrials |
| NCT03332030 | Stem Cells in NF1 Patients With Tumors of the Central Nervous System | withdrawn | — | 0 | Roger PackerOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT04019470 | Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors | withdrawn | — | 0 | Capital Medical UniversityOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT05373381 | The KetoGlioma (Ketogenic Glioma) Study | withdrawn | N/A | 0 | Tufts Medical CenterOTHER | 1 | Feb 2, 2024 | clinicaltrials |
| NCT04629209 | A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma | withdrawn | Phase 2 | 0 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 24, 2023 | clinicaltrials |
| NCT02432417 | The Addition of Chloroquine to Chemoradiation for Glioblastoma, | withdrawn | Phase 2 | 0 | Maastricht Radiation OncologyOTHER | 0 | Nov 18, 2023 | clinicaltrials |
| NCT04344626 | Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery | withdrawn | N/A | 0 | University of California, Los AngelesOTHER | 2 | Oct 10, 2023 | clinicaltrials |
| NCT03406273 | Standardized Protocol of Surgery and Radiation for Patients With Brain Metastases in Relapsed Neuroblastoma | withdrawn | N/A | 0 | Giselle ShollerOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05054400 | Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR | withdrawn | Early Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Sep 1, 2023 | clinicaltrials |
| NCT04427228 | Single vs Multi-fraction SRS Patients on Immunotherapy(MIGRAINE) | withdrawn | Phase 2 | 0 | University of ChicagoOTHER | 1 | Aug 28, 2023 | clinicaltrials |
| NCT05063357 | 131I-omburtamab Delivered by Convection-Enhanced Delivery in Patients With Diffuse Intrinsic Pontine Glioma | withdrawn | Phase 1 | 0 | Y-mAbs TherapeuticsINDUSTRY | 0 | Jun 26, 2023 | clinicaltrials |
| NCT04741984 | Monocyte Antigen Carrier Cells for Newly Diagnosed GBM(DEMAND) | withdrawn | Phase 1 | 0 | Michael GunnOTHER | 0 | May 15, 2023 | clinicaltrials |
| NCT05169151 | Mobility and Physical Activity in Adolescent and Young Adult Cancer Patients or Survivors at Risk for Cardiovascular Morbidity and Frailty, The MOBILE AYA Study | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 24, 2023 | clinicaltrials |
| NCT05410301 | Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma | withdrawn | N/A | 0 | Varun Monga, MDOTHER | 1 | Apr 21, 2023 | clinicaltrials |
| NCT03179449 | In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI | withdrawn | Early Phase 1 | 0 | Michael IvOTHER | 0 | Apr 14, 2023 | clinicaltrials |
| NCT03956706 | Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas | withdrawn | N/A | 0 | Northwell HealthOTHER | 1 | Mar 15, 2023 | clinicaltrials |
| NCT04276597 | Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.(PUTNET) | withdrawn | Phase 2 | 0 | Excel Diagnostics and Nuclear Oncology CenterOTHER | 1 | Mar 10, 2023 | clinicaltrials |
| NCT04650490 | SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer(STICk-IM-NSCLC) | withdrawn | Phase 2 | 0 | Duke UniversityOTHER | 1 | Mar 2, 2023 | clinicaltrials |
| NCT05222165 | Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations(NEWEL) | withdrawn | Phase 1 / Phase 2 | 0 | Helsinn Healthcare SAINDUSTRY | 3 | Feb 23, 2023 | clinicaltrials |
| NCT05356507 | The Effects of Spiritual Needs on Spiritual Well-Being in Patients With Brain Tumors: A Structural Equation Modeling Approach | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 2, 2023 | clinicaltrials |
| NCT05233215 | GROW (Glioma Specialists Reaching Out With Support) Support | withdrawn | N/A | 0 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT05017610 | Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma or Gliosarcoma | withdrawn | Early Phase 1 | 0 | Emory UniversityOTHER | 0 | Dec 2, 2022 | clinicaltrials |
| NCT00555711 | Monitoring Neural Tissues Properties by Modulated Imaging (MI)(MI) | withdrawn | — | 0 | University of California, IrvineOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT03649464 | Investigation of Oral OKN-007 in Recurrent High-grade Glioma Participants | withdrawn | Phase 1 / Phase 2 | 0 | Oblato, Inc.INDUSTRY | 0 | Oct 7, 2022 | clinicaltrials |
| NCT04776980 | Multimodality MRI and Liquid Biopsy in GBM | withdrawn | Early Phase 1 | 0 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Sep 16, 2022 | clinicaltrials |
| NCT03209869 | Treatment of Relapsed or Refractory Neuroblastoma and Osteosarcoma With Expanded Haploidentical NK Cells and Hu14.18-IL2 | withdrawn | Phase 1 | 0 | University of Wisconsin, MadisonOTHER | 1 | Sep 13, 2022 | clinicaltrials |
| NCT04909515 | Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GMCSF) and Isotretinoin for Consolidation of Patients With High-Risk Neuroblastoma in First Remission. | withdrawn | Phase 2 | 0 | Y-mAbs TherapeuticsINDUSTRY | 4 | Sep 1, 2022 | clinicaltrials |
| NCT04200066 | A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma | withdrawn | Phase 1 | 0 | University of RochesterOTHER | 0 | Aug 22, 2022 | clinicaltrials |
| NCT04926168 | 6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM) | withdrawn | — | 0 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 0 | Aug 10, 2022 | clinicaltrials |
| NCT04315246 | 177Lu-DTPA-Omburtamab Radioimmunotherapy for Leptomeningeal Metastasis From Solid Tumors (Breast, NSCLC, Malignant Melanoma) | withdrawn | Phase 1 / Phase 2 | 0 | Y-mAbs TherapeuticsINDUSTRY | 2 | Jul 15, 2022 | clinicaltrials |
| NCT04863339 | Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery | withdrawn | Phase 2 | 0 | University of North Carolina, Chapel HillOTHER | 0 | Apr 5, 2022 | clinicaltrials |
| NCT04065087 | Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma | withdrawn | Phase 1 / Phase 2 | 0 | Genexine, Inc.INDUSTRY | 1 | Mar 17, 2022 | clinicaltrials |
| NCT05247749 | CONVIVO System to Discriminate Healthy Tissues vs Tumor Tissues During Brain Tumor Resection | withdrawn | N/A | 0 | Stanford UniversityOTHER | 0 | Feb 21, 2022 | clinicaltrials |
| NCT04069910 | Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases | withdrawn | N/A | 0 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2022 | clinicaltrials |
| NCT03057678 | Evaluating the Pre-Positioning Frame for Robotic Acoustic Neuroma Removal Surgery(PPF) | withdrawn | N/A | 0 | Vanderbilt University Medical CenterOTHER | 1 | Jan 20, 2022 | clinicaltrials |
| NCT02567643 | Stereotactic Radiosurgery (SRS) for Multiple CNS Mets | withdrawn | N/A | 0 | The Cooper Health SystemOTHER | 1 | Jan 11, 2022 | clinicaltrials |
| NCT05061251 | Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma | withdrawn | Early Phase 1 | 0 | University of Texas Southwestern Medical CenterOTHER | 0 | Jan 11, 2022 | clinicaltrials |
| NCT01331616 | Optic Neuropathy in 10 Patients With Glioblastoma Receiving Bevacizumab | withdrawn | Early Phase 1 | 0 | West Penn Allegheny Health SystemOTHER | 0 | Dec 9, 2021 | clinicaltrials |
| NCT03234309 | Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain Tumors | withdrawn | Phase 2 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | Nov 10, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Sep 3, 2024source: clinicaltrials